Does obesity predict bipolarity in major depressive patients?
Giulia Vannucchi1, Cristina Toni2, Icro Maremmani3
1Department of Clinical and Experimental Medicine, Unit of Psychiatry, University of Pisa, Pisa, Italy.
Journal of Affective Disorders
|November 12, 2013
Summary
Obesity in Major Depressive Episode (MDE) patients is linked to bipolar disorder and manic symptoms, suggesting a potential shared mechanism. Further research is needed to understand this association.
Area of Science:
- Psychiatry
- Clinical Psychology
- Epidemiology
Background:
- The relationship between obesity and Major Depressive Episode (MDE) subtypes, specifically bipolar versus unipolar, remains under-investigated.
- This study aims to clarify the association between obesity and the presence of manic or hypomanic symptoms in a large clinical sample of MDE patients.
Purpose of the Study:
- To investigate the differential association of obesity in bipolar and unipolar Major Depressive Episode (MDE).
- To explore the relationships between obesity and history of manic and hypomanic symptoms in MDE patients.
Main Methods:
- A sample of 571 MDE patients from 30 Italian outpatient psychiatric facilities were assessed.
- Height and weight were measured to calculate Body Mass Index (BMI); a BMI >30 defined obesity.
- The Hypomania Check List-32 (HCL-32) was used to evaluate lifetime manic or hypomanic features.
Main Results:
- Obesity (BMI >30) was identified in 15.1% of MDE patients.
- Obese patients had lower educational attainment and were more frequently married compared to non-obese patients.
- Obesity was significantly more prevalent in patients with bipolar MDE and higher HCL-32 scores, with bipolar subtype being the strongest predictor of obesity.
Conclusions:
- Obesity in MDE patients is associated with the bipolar subtype and the presence of (hypo)manic symptoms.
- These findings suggest a potential link between obesity and bipolarity, possibly mediated by an impulsive-addictive diathesis.
- Further longitudinal studies are recommended to elucidate the role and burden of obesity in bipolar disorder.
Related Concept Videos
Bipolar Disorder
1.4K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445


